Melatonin may add to meclizine-related sleepiness or impairment. Review the dose and formulation, particularly if you already feel drowsy; the exact combination’s risk has not been quantified.
Melatonin may add to metaxalone-related drowsiness or impairment. The exact combination risk is unmeasured, so have co-use reviewed rather than relying on a timing gap.
Melatonin may add to midazolam-related impairment, but a monitored surgical co-use trial did not show a significant sedation difference. The exact preparation, setting and other medicines matter.
Review melatonin before adding it to nortriptyline. Severe sedation has been reported during co-use, although citalopram and oxycodone were also present and prevent isolating this pair.
Melatonin may add to orphenadrine-related drowsiness or impaired alertness. Review the exact product and other sedating medicines before adding it; this combination’s risk has not been measured directly.
Melatonin may add to promethazine-related sleepiness or impairment. Review the dose and formulation, particularly if you already feel drowsy; the exact combination’s risk has not been quantified.
Melatonin can cause drowsiness, so review it with your prescriber when taking ropinirole. The combination has not been shown to require a particular dose interval or a change in melatonin need. Small Parkinson disease trials also found improved sleep outcomes.
Ask the prescriber before adding melatonin to temazepam. Melatonin product guidance cautions about benzodiazepine sedation, but direct temazepam combination evidence is limited.
Melatonin may add to thiothixene-related sleepiness. The exact clinical risk is not quantified, and laboratory or animal studies do not establish a safe dose or timing plan.